Predicted to enable mRNA 3'-UTR binding activity and mRNA base-pairing translational repressor activity. Involved in several processes, including cellular response to estradiol stimulus; negative regulation of gap junction assembly; and positive regulation of cytokine production. Predicted to be located in P-body and extracellular exosome. Predicted to be part of RISC complex. Used to study osteonecrosis. Biomarker of cardiac arrest. Orthologous to human MIR23A (microRNA 23a); INTERACTS WITH 3,7-dihydropurine-6-thione; aflatoxin B1; aristolochic acid A.
Arsenic Trioxide inhibits the reaction [PRAM1 protein results in decreased expression of MIR23A mRNA] and MIR23A mRNA promotes the reaction [Arsenic Trioxide results in decreased expression of and affects the localization of and results in decreased activity of KCNH2 protein]
Arsenic Trioxide inhibits the reaction [PRAM1 protein results in decreased expression of MIR23A mRNA] and MIR23A mRNA promotes the reaction [Arsenic Trioxide results in decreased expression of and affects the localization of and results in decreased activity of KCNH2 protein]
Mifepristone inhibits the reaction [ginsenoside Rg1 results in decreased expression of MIR23A mRNA] and MIR23A mRNA inhibits the reaction [ginsenoside Rg1 results in increased expression of MET protein]